1Herbert Ho Fung Loong
The Chinese University of Hong Kong (CUHK)
The 2026 Summit serves as a premier academic forum, uniting regional and international leaders to bridge the gap between innovation and impact. Our focus is the translation of ctDNA (circulating tumor DNA), multi-omics, and Artificial Intelligence integration into structured, real-world oncology practice across the Asia-Pacific region.
As a flagship initiative of the K-CONNECT PLATFORM supported by Gene Solutions, the summit fosters a collaborative ecosystem for oncologists and researchers. We are dedicated to accelerating research and driving innovation in critical fields, including ctDNA–MRD (Minimal Residual Disease), and Comprehensive Genomic & Transcriptomic Profiling (CGTP).
Together, we aim to strengthen regional ties and advance the clinical implementation of precision oncology—integrating molecular data into the entire patient journey, from routine screening to long-term disease monitoring.
Gene Solutions envisions elevating healthcare in Asia through multi-dimensional genomics and AI, committed to accessible genetic testing services.
The Chinese University of Hong Kong (CUHK)
Vajira Hospital, Navamindradhiraj University
Bridging the gap in genomic insights across the Asia-Pacific region
National Taiwan University Hospital
Medical Genetics Institute, Vietnam
The Chinese University of Hong Kong (CUHK)
University of Sydney, Australia
The University of Hong Kong (HKU)
Hospital Picaso, Malaysia
Principal Investigator, Gene Solutions
Nanavati Max Super Speciality Hospital
Principal Investigator, Gene Solutions
